M Performance Standards for Antimicrobial. Susceptibility Testing. This document includes updated tables for the Clinical and. Laboratory Standards. The tables in CLSI document M,1 when used in conjunction with this standard, represent the most current information for drug selection. [DOWNLOAD] Clsi Guidelines M S23 PDF [BOOK]. Book file PDF easily for everyone and every device. You can download and read online.
|Published (Last):||24 December 2018|
|PDF File Size:||5.41 Mb|
|ePub File Size:||4.75 Mb|
|Price:||Free* [*Free Regsitration Required]|
Laboratory identification of MRSA is crucial and essential both for initiation of appropriate antimicrobial therapies and for effective infection control strategies that are designed to limit the spread of MRSA.
Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States. Author information Article notes N100 and License information Disclaimer. Expanded recommendations for testing fluoroquinolones and salmonella, and elimination breakpoints for beta-lactamase, other than oxacillin cefoxitinpenicillin, and ceftaroline for staphylococci are included.
Address correspondence to David J. Oritavancin activity against Staphylococcus aureus causing invasive infections in USA and European hospitals. Food and Drug Administration.
Updated Version of CLSI’s Best-Selling Standard-MSis Now Available – IFCC
TABLE 1 MIC result variations and summary of essential agreement rates between previously established broth microdilution method and revised reference method for telavancin.
It is also important to mention that although this revised method provides lower MIC determinations for telavancin, the antimicrobial susceptibility profile remains similar to that established by using the previous BMD method 1213— Update on the telavancin activity tested against European staphylococcal clinical isolates Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA hospitals Abstract The reference broth microdilution BMD antimicrobial susceptibility testing method for telavancin was revised to include dimethyl sulfoxide DMSO as a solvent and diluent for frozen-form panel preparation, following the CLSI recommendations for water-insoluble agents.
Nevertheless, some studies have shown that results obtained clsl such phenotypic methods are controversial. This article has been cited by other articles 2s3 PMC. Several Sensititre dry-form broth microdilution panel candidate formulations eight were manufactured and tested simultaneously with the previous and revised frozen-form panels.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M10 Clinical and Laboratory Standards Institute CLSI is a not-for-profit membership organization that brings together the cllsi perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: Polysorbate 80 P was also added to the test medium to w23 proven drug losses associated with binding to plastic surfaces.
The antimicrobial susceptibility testing for these lipoglycopeptide agents was revised 67and updated quality control QC ranges for dalbavancin and oritavancin were established and published by the Clinical and Laboratory Standards Institute CLSIin MS24 and previous documents 8. Telavancin MIC values obtained by the revised method were considered reference results for these analyses.
Surfactants, such as P, act as wetting agents and are commonly used in commercially prepared antimicrobial agent susceptibility testing panels or as part of the inoculum for broth microdilution assays to aid in the homogenous dispersal of reagents or to ensure their quantitative recovery from solution 45.
Footnotes Published ahead of print 14 July Second, a challenge set of organisms 56 strains displaying decreased antimicrobial susceptibilities to several key comparator agents were selected and included in this study, as follows: As previously observed with dalbavancin 4 and oritavancin 5the data presented here, using a large collection of clinically relevant strains, shows that the revised BMD method containing the addition of P common to all three lipoglycopeptides provides lower MIC results than those obtained by the previous method, especially when tested against staphylococci and enterococci.
A five-year international surveillance program. Performance standards for antimicrobial susceptibility testing: In contrast, when tested against streptococci, the impact of the revised method on the telavancin MIC results was less pronounced, which was similar to those observed for the other lipoglycopeptides 45. Effect of polysorbate 80 on oritavancin binding to plastic surfaces: During the development of this revised method, previous telavancin MIC determinations obtained when P was added only at the latest step bacterial inoculation resulted in MIC values against S.
MIC result variations and summary of essential agreement rates between dry-form broth microdilution formulation panel Sensititre and revised reference method for telavancin.
These results also were observed for oritavancin, indicating that the presence of P at 0. In contrast, the disk diffusion methods with oxacillin and cefoxitin showed lower sensitivity Surveillance of dalbavancin potency and spectrum in the United States South San Francisco, CA.
Advancing excellence in laboratory medicine for better healthcare worldwide. Published ahead of print 14 July During the development of dalbavancin, also a lipoglycopeptide, the use of polysorbate 80 P 0.
Communications and Publications
Less-significant MIC decreases 1 to 2 log 2 dilution steps were observed when testing streptococci in broth supplemented with blood, which showed similar MIC 50 values for both methods. Initial studies using this revised method observed that the MIC 50 results for telavancin were 4- to 8-fold lower than those obtained by the previous applied method use of DMSO and water as solvent and diluent for panel preparation, respectively, and no P supplementation when tested against staphylococci and enterococci, but minimal differences were observed when testing streptococci data on file; JMI Laboratories.
Similar experiments were performed ,100 telavancin, and similar results were obtained data on file; Theravance, Inc. However, Streptococcus pneumoniae had MIC 50 results of 0. Advances in MicrobiologyVol. Journal List Antimicrob Agents Chemother v.